Trend analysis of the long-term Swiss ozone measurements

Trend analyses, assuming a linear trend which started at 1970, were performed from total ozone measurements from Arosa (Switzerland, 1926-1991). Decreases in monthly mean values were statistically significant for October through April showing decreases of about 2.0-4 percent per decade. For the period 1947-91, total ozone trends were further investigated using a multiple regression model. Temperature of a mountain peak in Switzerland (Mt. Santis), the F10.7 solar flux series, the QBO series (quasi biennial oscillation), and the southern oscillation index (SOI) were included as explanatory variables. Trends in the monthly mean values were statistically significant for December through April. The same multiple regression model was applied to investigate the ozone trends at various altitudes using the ozone balloon soundings from Payerne (1967-1989) and the Umkehr measurements from Arosa (1947-1989). The results show four different vertical trend regimes: On a relative scale changes were largest in the troposphere (increase of about 10 percent per decade). On an absolute scale the largest trends were obtained in the lower stratosphere (decrease of approximately 6 per decade at an altitude of about 18 to 22 km). No significant trends were observed at approximately 30 km, whereas stratospheric ozone decreased in the upper stratosphere

Schlüssel zur Einteilung von Neophyten in der Schweiz in die Schwarze Liste oder die Watch-Liste

No Abstrac

Retrospective Analysis of Efficacy and Toxicity of Stereotactic Body Radiotherapy and Surgical Resection of Adrenal Metastases from Solid Tumors.

BACKGROUND This single-center retrospective study aimed to evaluate the efficacy and toxicity profiles of stereotactic body radiotherapy (SBRT) and surgical resection in patients with adrenal metastases originating from solid tumors. METHODS/MATERIALS Patients with advanced tumor conditions or comorbidities typically received SBRT, whereas those considered physically fit underwent standard surgical treatment. Endpoints included local control (LC), progression free survival (PFS), overall survival (OS), and complication rates (CR). RESULTS 41 patients with 48 adrenal metastases were included, with 27 (65.9%) patients receiving SBRT and 14 (34.1%) patients undergoing adrenalectomy. One- and two-year LC values were 100% for both periods after adrenalectomy, and 70.0% and 52.5% after SBRT (p = 0.001). PFS showed values of 40.2% and 32.1% at one and two years after adrenalectomy and of 10.6% for both periods after SBRT (p = 0.223). OS was 83.3% both one and two years after surgery and 67.0% and 40.2% after SBRT (p = 0.031). There was no statistically significant difference between the two groups regarding acute complications (p = 0.123). CONCLUSION Despite potential confounders, adrenalectomy exhibited statistically significant superior LC and OS compared to SBRT in managing adrenal metastases, while both treatment methods displayed acceptable toxicity profiles. However, patient selection bias must be taken into account when directly comparing the two therapy modalities. Nevertheless, the study provides new and important results for the scientific and medical communities regarding oncological outcomes after SBRT or surgical resection of adrenal metastases